Adaptive Biotechnologies (ADPT) reported Loss for second quarter that decreased from last year and beat the Street estimates.
The company's earnings came in at -$47.81 million, or -$0.33 per share. This compares with -$52.05 million, or -$0.37 per share, in last year's second quarter.
Analysts on average had expected the company to earn -$0.35 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 12.1% to $48.93 million from $43.66 million last year.
Adaptive Biotechnologies earnings at a glance (GAAP) :
-Earnings (Q2): -$47.81 Mln. vs. -$52.05 Mln. last year.-EPS (Q2): -$0.33 vs. -$0.37 last year.-Analyst Estimates: -$0.35-Revenue (Q2): $48.93 Mln vs. $43.66 Mln last year.
-Guidance:Full year revenue guidance: $205 mln to $215 mln
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.